CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · IEX Real-Time Price · USD
4.780
+0.030 (0.63%)
At close: Jul 26, 2024, 3:53 PM
4.570
-0.210 (-4.39%)
After-hours: Jul 26, 2024, 7:39 PM EDT
CollPlant Biotechnologies Revenue
CollPlant Biotechnologies had revenue of $98.00K in the quarter ending March 31, 2024, a decrease of -77.37%. This brings the company's revenue in the last twelve months to $10.62M, up 1,495.20% year-over-year. In the year 2023, CollPlant Biotechnologies had annual revenue of $10.96M with 3,565.22% growth.
Revenue (ttm)
$10.62M
Revenue Growth
+1,495.20%
P/S Ratio
5.15
Revenue / Employee
$141,653
Employees
75
Market Cap
54.75M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 10.96M | 10.66M | 3,565.22% |
Dec 31, 2022 | 299.00K | -15.34M | -98.09% |
Dec 31, 2021 | 15.64M | 9.50M | 154.86% |
Dec 31, 2020 | 6.14M | 3.82M | 164.75% |
Dec 31, 2019 | 2.32M | -2.70M | -53.77% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Rockwell Medical | 86.62M |
Neuronetics | 73.23M |
Allurion Technologies | 48.78M |
Cidara Therapeutics | 46.38M |
Cytosorbents | 36.69M |
MSP Recovery | 9.71M |
Barinthus Biotherapeutics | 334.00K |
CLGN News
- 7 weeks ago - CollPlant Successfully Bio-Prints 200cc Commercial-Size Regenerative Breast Implants and Reports Additional Positive Pre-Clinical Data - PRNewsWire
- 2 months ago - CollPlant Biotechnologies Announces First Quarter Financial Results For 2024 and Provides Corporate Update - PRNewsWire
- 2 months ago - COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FIRST QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION - PRNewsWire
- 4 months ago - COLLPLANT BIOTECHNOLOGIES REPORTS 2023 FULL YEAR FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE - PRNewsWire
- 4 months ago - COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION - PRNewsWire
- 5 months ago - CollPlant Issues Letter to Shareholders - PRNewsWire
- 7 months ago - CollPlant's CEO to Present at the Octane Aesthetic Tech Forum Conference, in Newport Beach, California - PRNewsWire
- 7 months ago - CollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants - PRNewsWire